Hyderabad-based Contract Development & Manufacturing Organization, Sai Life Sciences has announced the appointment ofJay Stellaas Chief Business Officer, to lead the overall business development and program management for the company. Jay will be based out ofCambridge, Massachusetts,United Statesand will report to the CEO & Managing Director,Krishna Kanumuri.

Jay Stellabrings over 25 years of leadership in the pharmaceutical and medical devices industries with extensive experience across R&D, manufacturing, business development, finance, and post-M&A integrations. He held positions of increasing responsibility at Millennium Pharmaceuticals and Takeda Pharmaceuticals for 15 years, across strategy & operations, business development, and integrations & divestitures, while also gaining significant experience in the Japanese cultural and business environment.

Earlier, he worked for medium sized biotech companies, Biogen and Genetics Institute, where he held various financial and operational roles. Prior to the pharmaceutical industry, Jay worked in technical operations, manufacturing, planning, and strategic sourcing roles in the medical device industry. Jay received his MBA fromBoston Universityand his Baccalaureate degree from theUniversity of Vermontin Spanish with minors in Chemistry and Biology.

Making the announcement,Krishna Kanumurisaid, “Inducting top-notch global leadership and scientific talent is a key priority as part of our transformative effort,Sai Nxt. We are delighted to have Jay on board in this exciting phase.”

Jay will be based out of Cambridge, United States and will report to the CEO & Managing Director, Krishna Kanumuri.